155 related articles for article (PubMed ID: 33439044)
1. Frequency and Outcomes of New Suspicious Lesions on Breast MRI in the Setting of Neoadjuvant Therapy.
Eckstein DA; Price ER; Hayward JH; Joe BN; Lee AY
AJR Am J Roentgenol; 2021 Mar; 216(3):633-639. PubMed ID: 33439044
[No Abstract] [Full Text] [Related]
2. A Diagnostic Dilemma: New Enhancing Suspicious Findings on Breast MRI Following Neoadjuvant Chemotherapy.
LaRoy JR; Tadros AB; Sevilimedu V; Mango VL
J Breast Imaging; 2023 Jul; 5(4):453-458. PubMed ID: 38416906
[TBL] [Abstract][Full Text] [Related]
3. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
4. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Magnetic Resonance-Guided Vacuum-Assisted Large-Volume Breast Biopsy (MR-Guided VALB).
Schrading S; Strobel K; Keulers A; Dirrichs T; Kuhl CK
Invest Radiol; 2017 Mar; 52(3):186-193. PubMed ID: 27861232
[TBL] [Abstract][Full Text] [Related]
6. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
[TBL] [Abstract][Full Text] [Related]
7. Real-time virtual sonography examination and biopsy for suspicious breast lesions identified on MRI alone.
Uematsu T; Takahashi K; Nishimura S; Watanabe J; Yamasaki S; Sugino T; Oishi T; Kakuda Y; Sato M; Hayashi T
Eur Radiol; 2016 Apr; 26(4):1064-72. PubMed ID: 26135000
[TBL] [Abstract][Full Text] [Related]
8. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
[TBL] [Abstract][Full Text] [Related]
10. The Positive Outcome of MRI-Guided Vacuum Assisted Core Needle Breast Biopsies Is Not Influenced by a Prior Negative Targeted Second-Look Ultrasound.
Ferré R; AlSharif S; Aldis A; Mesurolle B
Can Assoc Radiol J; 2017 Nov; 68(4):401-408. PubMed ID: 28835335
[TBL] [Abstract][Full Text] [Related]
11. Additional findings at preoperative breast MRI: the value of second-look digital breast tomosynthesis.
Clauser P; Carbonaro LA; Pancot M; Girometti R; Bazzocchi M; Zuiani C; Sardanelli F
Eur Radiol; 2015 Oct; 25(10):2830-9. PubMed ID: 25903704
[TBL] [Abstract][Full Text] [Related]
12. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
13. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
14. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
15. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
Edmonds CE; Lamb LR; Mercaldo SF; Sippo DA; Burk KS; Lehman CD
AJR Am J Roentgenol; 2020 Feb; 214(2):240-248. PubMed ID: 31799867
[No Abstract] [Full Text] [Related]
16. MRI-guided wire localization open biopsy is safe and effective for suspicious cancer on breast MRI.
Wang HY; Zhao YN; Wu JZ; Wang Z; Tang JH
Asian Pac J Cancer Prev; 2015; 16(5):1715-8. PubMed ID: 25773814
[TBL] [Abstract][Full Text] [Related]
17. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
19. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
[TBL] [Abstract][Full Text] [Related]
20. The Role of Breast MRI in Detecting Asymptomatic Recurrence After Therapeutic Mastectomy.
Chapman MC; Hayward JH; Woodard GA; Joe BN; Lee AY
AJR Am J Roentgenol; 2020 Jul; 215(1):254-261. PubMed ID: 32374666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
